Healthtech Startups

Eurofins Viracor is a clinical laboratory that develops and delivers diagnostic tests for infectious diseases, cellular function disorders, oncology, and transplant rejection monitoring. The company serves healthcare providers and patients in the United States through comprehensive laboratory services and biomarker research.

1 investor

EUROLyser develops diagnostic testing systems and parameters, including a beta-Hydroxybutyrate (BHB) test aimed at veterinarians for measuring ketone bodies. The company operates in the medical/veterinary diagnostics field.

1 investor

Europa Eyewear operates an eyewear catalog and distribution business, serving retailers and brands through a product and brand management platform.

1 investor

Archimica is a contract manufacturer of active pharmaceutical ingredients (APIs), GMP building blocks and reagents, offering process development and production from clinical to large commercial scale for innovative and generic pharmaceutical companies. Operating from its Lodi site in Italy, it specializes in hazardous and difficult chemistry including anticancer APIs, and supplies customers across roughly 50 countries.

1 investor

Evaheart develops implantable and extracorporeal ventricular assist devices for heart failure and vascular disease treatment. The company manufactures medical devices and operates an integrated ecosystem including research, production, and clinical solutions.

1 investor

Evec (株式会社イーベック) is a Japanese biotechnology company that develops fully human monoclonal antibodies through its research labs. The page is a corporate officers/executive profile page listing the company's board members and auditors.

1 investor

Eveliqure develops a live attenuated vaccine platform for oral administration targeting Shigella and ETEC pathogens that cause diarrheal disease in travelers and populations in low- and middle-income countries. The company's lead product, ShigETEC, provides broad serotype-independent protection against multiple pathogens through targeted genetic mutations.

1 investor

Evenly provides a managed Invisalign service for dental and orthodontic practices, handling treatment planning, patient consultations, and remote monitoring so practices can keep clear aligner cases in-house. Its orthodontists build customized treatment plans and use technology for weekly patient check-ins.

1 investor

Eventum Orthopaedics develops Quadsense, a medical device that provides real-time intraoperative data to surgeons during total knee arthroplasty procedures, helping optimize patellar positioning and patient outcomes. The company also builds Datasense, a data analysis tool for preoperative, intraoperative, and postoperative decision-making in knee surgery.

1 investor

Eventus WholeHealth is a healthcare organization that delivers patient care and invests in technology, data and analytics, and clinical platforms to support its operations and growth.

1 investor

Evergreen Theragnostics manufactures radiopharmaceutical therapeutics and diagnostics for cancer treatment and develops novel radiotherapeutic agents for cancer patients. The company offers high-quality manufacturing services and handles product registration and commercialization for partner companies.

1 investor

Evergreen provides patient support and management services for people with kidney disease, partnering with nephrologists and healthcare providers to deliver personalized care addressing physical, emotional, and social needs.

1 investor

Evergrove Labs builds voice AI agents purpose-built for the workers' compensation industry, running end-to-end phone calls and handling data retrieval and entry in systems of record to replace contact center staff. The agents run in parallel across claims workflows and connect to claims management systems, Salesforce, and custom systems of record.

1 investor

Everhope operates cancer care centres in India that provide oncology treatment along with support for patients and caregivers. It positions its facilities as patient-centred sanctuaries rather than traditional hospitals, with locations in Gurugram.

1 investor

Everlong is a nutrition platform that pairs patients with registered dietitian nutritionists (RDNs) to build sustainable eating habits and long-term health improvements through personalized coaching and behavior change support.

1 investor

EVERSANA is an independent provider of integrated commercial services to the life sciences industry, supporting products across all stages of their life cycle. It serves over 670 organizations, including startups and established pharmaceutical companies, addressing the needs of patients, prescribers, channel partners and payers.

1 investor

Bariendo (Everself) offers ESG (endoscopic sleeve gastroplasty), a one-time, non-surgical endoscopic procedure that reduces stomach size for lasting weight loss, paired with a year of concierge weight-care support from physicians, dietitians, and coaches delivered through an app. It serves patients seeking obesity and weight-loss treatment.

1 investor

Marathon Health provides advanced primary care combined with lifestyle and chronic condition management for employers and health plans, using health coaches and registered dietitians alongside providers. It delivers services through onsite, nearsite, and network health centers as well as virtual care across the US, covering areas like GLP-1 support, diabetes, hypertension, and cardiometabolic risk management.

1 investor

Everyplus operates a recreation and event platform for care facilities, providing residents with expanded choices and opportunities for engagement through organized activities and experiences.

1 investor

EVerZom develops exosome formulation technologies that modify cells to release exosomes with enhanced therapeutic properties, designed for targeted delivery to specific tissue sites. The company creates formulated exosome drugs for treating pathologies through local or systemic administration routes.

1 investor

Evestia Clinical is a clinical research organization providing clinical trial services for biotech companies across oncology, rare disease, neurology, immunology, and inflammation. The company was established in 1996 and recently rebranded to reflect its expanded focus as a global clinical research provider.

1 investor

EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling. The company uses AI-powered platforms to identify EV subpopulations with therapeutic potential and enables targeted drug delivery for oncology applications.

1 investor

Evidence Action is a nonprofit organization that implements evidence-based interventions to reduce inequality and improve lives in global health, water, sanitation, and education. The organization works across Africa and India to scale programs addressing maternal and child health, deworming, safe water access, nutrition, and school health.

1 investor

Evidentli develops biomedical AI technology for health data analysis and clinical decision support. The company serves healthcare systems, researchers, and clinical organizations seeking to convert health data into actionable insights and enable collaboration across the healthcare ecosystem.

1 investor